Formulation and stability of extemporaneous cyclosporine eye drops compounded from cyclosporine commercial products
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: DRASKOVIC, Jasmina (Pharmacy 'Belgrade', Belgrade, Yugoslavia)
- Co-author(s): Milic, Jela (Faculty of Pharmacy, Belgrade, Serbia)
Zirojevic, Jelena (Agency of Drugs and Medicinal Devices of Serbia, Belgrade, Serbia)
Jovic, Zarko (Agency of Drugs and Medicinal Devices of Serbia, Belgrade, Serbia)
In the modern therapy of „dry eye syndrome“ are used eye drops with cyclosporine. On the our market today aren't available commercially manufactured product with cyclosporine. Because that are the need for exteporaneous compounding from cyclosporine commercial products: for the oral use (Sandimmun® Neoral) and intravenous administration.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.